Key facts
- Notable investors include Incubate Fund, Genesia Ventures, QR Investment, Samurai Incubate, Dojin Capital — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for CA Medlynks
- ·The full record, as it builds
Funding rounds
No funding rounds for CA Medlynks are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CA Medlynks
Developer of a diagnostic laboratory platform designed to advance healthcare through accurate and timely testing services. The company offers multilevel laboratory sections, advanced diagnostic technologies, and strategic collaborations with medical professionals, enabling patients and healthcare providers in Kenya to access precise diagnostics and expert medical consultation.
- Sector
- Healthcare
- HQ
- Nairobi, Kenya
- Founded
- 2018
- Employees
- 40
- Website
- camedlynks.com/
- Ownership
- Privately Held (backing)
CA Medlynks doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CA Medlynks shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CA Medlynks in its N-PORT filings yet. We sweep new filings monthly.